Nicholette Zeliadt manages The Transmitters’s staff reporters and interns, and she commissions and edits news articles. She joined The Transmitter as news writer in 2014. Before that, she was a freelance writer and editor. Her work has appeared in The New York Times, Scientific American, Nature Medicine, Science and The Scientist.

Nicholette Zeliadt
Managing editor
The Transmitter
From this contributor

Leaving lasting marks with Tessa Montague

Spotted around the web: INSAR; cerebellar gene expression; pangenome
Spotted around the web: Mapping histones; COVID-19 births; acetaminophen lawsuits

New diagnostic code for PTEN syndrome may spur research
Education
- Ph.D. in environmental health, University of Minnesota
- B.A. in biochemistry, University of Iowa
Fellowships
- AAAS Mass Media Fellowship
Explore more from The Transmitter
Deleting data or stopping its collection will erase years of valuable brain research
An explosion in open-neuroscience datasets has created a new generation of researchers with expertise in data science. But new federal restrictions in the United States put their research programs in jeopardy.

Deleting data or stopping its collection will erase years of valuable brain research
An explosion in open-neuroscience datasets has created a new generation of researchers with expertise in data science. But new federal restrictions in the United States put their research programs in jeopardy.
Up and out with Peggy Mason
Mason helped define the rodent prosocial behavior field, but now she’s changing course.

Up and out with Peggy Mason
Mason helped define the rodent prosocial behavior field, but now she’s changing course.
The spectrum goes multidimensional in search of autism subtypes
Grouping people with autism based on shared features, genetics and co-occurring conditions may improve clinical trial outcomes, researchers say.

The spectrum goes multidimensional in search of autism subtypes
Grouping people with autism based on shared features, genetics and co-occurring conditions may improve clinical trial outcomes, researchers say.